Get started
Author

Mathias Warm

Observed names: M Warm, M. Warm, M.A. Warm, Mathias A. Warm, Warm, Mathias
Observed institutions: Witten/Herdecke University, University of Cologne, Friedrich-Alexander-Universität Erlangen-Nürnberg, Heidelberg University, University Hospital Heidelberg, Medizinische Hochschule Hannover, Universitätsklinikum Erlangen, Sankt Gertrauden Krankenhaus, Hospital Clínic de Barcelona, Klinikum Esslingen, Essen University Hospital, Marien Hospital Witten, Kliniken der Stadt Köln, German Breast Group, University Hospital Magdeburg, Helios Kliniken, Sana Klinikum Offenbach, Kliniken Essen-Mitte, Rotkreuzklinikum München, Comprehensive Cancer Center Erlangen, University Hospital Cologne, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Krankenhaus Köln-Holweide, Technical University of Munich, Charité – Universitätsmedizin Berlin
OpenAlex ID: A5088032345
NAB-Paclitaxel Improves Disease-Free Survival in Early Breast Cancer: GBG 69–GeparSepto
2019 · Michael Untch, Christian Jackisch, et al. · Journal of Clinical Oncology · 157
Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German setting
2012 · J. U. Blohmer, M. Rezai, et al. · Journal of Medical Economics · 55
PDF
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study
2016 · On behalf of the PELICAN Investigators, Nadia Harbeck, et al. · Breast Cancer Research and Treatment · 50
PDF
Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple‐negative early breast cancer: Primary translational analysis of the WSG‐ADAPT‐TN trial
2019 · Oleg Gluz, Cornelia Kolberg‐Liedtke, et al. · International Journal of Cancer · 49
De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial
2022 · Oleg Gluz, Ulrike Nitz, et al. · Clinical Cancer Research · 40
Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial
2021 · Monika Graeser, Friedrich Feuerhake, et al. · Journal for ImmunoTherapy of Cancer · 29
PDF
The V109G Polymorphism of the p27 Gene CDKN1B Indicates a Worse Outcome in Node-Negative Breast Cancer Patients
2004 · Thomas Schöndorf, Lewin Eisele, et al. · Tumor Biology · 25
PDF
Cognitive Behavioral Therapy in Breast Cancer Patients - a Feasibility Study of an 8 Week Intervention for Tumor Associated Fatigue Treatment
2015 · Christian Eichler, Multhaupt Pia, et al. · Asian Pacific Journal of Cancer Prevention · 24
PDF
Association of the Vitamin D Receptor Genotype with Bone Metastases in Breast Cancer Patients
2003 · Thomas Schöndorf, Carsten Eisberg, et al. · Oncology · 24
Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial
2022 · Cornelia Kolberg-Liedtke, Friedrich Feuerhake, et al. · Breast Cancer Research · 23
PDF
Geriatric assessment and biomarkers in patients with metastatic breast cancer receiving first-line mono-chemotherapy: Results from the randomized phase III PELICAN trial
2017 · Friedemann Honecker, Nadia Harbeck, et al. · Journal of Geriatric Oncology · 14
Abstract GS4-04: Endocrine therapy alone in patients with intermediate or high-risk luminal early breast cancer (0-3 lymph nodes), Recurrence Score <26 and Ki67 response after preoperative endocrine therapy: Primary outcome results from the WSG-ADAPT HR+/HER2- trial
2021 · Nadia Harbeck, Oleg Gluz, et al. · Cancer Research · 12
No-drain mastectomy - Preventing seroma using TissuGlu®: A small case series
2014 · Christian Eichler, Faten Dahdouh, et al. · Annals of Medicine and Surgery · 10
PDF
Underfinancing of 90.3% for Implant Costs of Prostheses and Expanders in DRG Revenues for Uni- and Bilateral Mastectomy with Immediate Breast Reconstruction
2010 · Volker R. Jacobs, Linda Rasche, et al. · Onkologie · 10
Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer
2025 · Lisa Richters, Oleg Gluz, et al. · JAMA Network Open · 9
Abstract GS5-06: No survival benefit of chemotherapy escalation in patients with pCR and “high-immune” triple-negative early breast cancer in the neoadjuvant WSG-ADAPT-TN trial
2019 · O Gluz, U Nitz, et al. · Cancer Research · 8
P206 German multicentre decision impact study of Oncotype DX recurrence score (RS) on adjuvant treatment in estrogen receptor positive (ER+) node negative (N0) and node positive (N+) early breast cancer
2011 · J.-U. Blohmer, T. Kühn, et al. · The Breast · 7
PDF
P2-12-26: Impact of the Recurrence Score on Adjuvant Decision-Making in ER-Positive Early Breast Cancer – Results of a Large Prospective Multicentre Decision Impact Study in Node Negative and Node Positive Disease.
2011 · M Rezai, W Eiermann, et al. · Cancer Research · 5
Komplikationen in der Mammachirurgie – Serome
2014 · S. Paepke, J. Blohmer, et al. · Senologie - Zeitschrift für Mammadiagnostik und -therapie · 4
Pathological complete response rate and survival in patients with BRCA-associated triple-negative breast cancer after 12 weeks of de-escalated neoadjuvant chemotherapy: Translational results of the WSG-ADAPT TN randomized phase II trial (NCT01815242).
2021 · Lisa Katharina Katharina Richters, Oleg Gluz, et al. · Journal of Clinical Oncology · 3
Aktuelle Entwicklung der Inzidenz und Mortalit�t beim Mammakarzinom
2003 · V. F. H�bbel, K. Rhiem, et al. · Der Gynäkologe · 3
PharmaNews
2016 · Demetrios Moris, Michalis Kontos, et al. · Breast Care · 2
PDF
Zoledronat in der adjuvanten Therapie des rezeptornegativen Mammakarzinoms – Rationale und Erfahrungen mit Einzelfallentscheidungen
2010 · S. Paepke, J. Blohmer, et al. · Senologie - Zeitschrift für Mammadiagnostik und -therapie · 2
Digitale Röntgenmammographie: Bildqualitativer Vergleich eines Nasslaserdruckers, eines infrarotbasierten Trockenlaserdruckers und eines thermographiebasierten Trockendruckers
2005 · B Krug, H Stützer, et al. · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · 2
PharmaNews
2016 · Demetrios Moris, Michalis Kontos, et al. · Breast Care · 1
Works count: 71
Citation count: 571
H-index: 12
I10-index: 14
Year
Topic
Type